Tratamiento farmacológico de la ambliopía pediátrica, con Levodopa oral a dosis mínima añadido a la terapia con oclusión

meta-análisis. European journal of ophthalmology año – 2012

16. – Hertle RW et al. Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years. Archives of Ophthalmology 2007; 125(5): 655-9.

17.- Carrión Ojeda Carlos et al. Ametropía y ambliopía en escolares de 42 escuelas del programa «Escuelas Saludables» en la DISA II, Lima. Perú, 2007-2008. Acta méd. Peruana [online]. 2009, vol.26, n.1, pp. 17-21. ISSN 1728-5917.

18. – Tejedor J, Ogallar C. Comparative efficacy of penalization methods in moderate to mild amblyopia. American Journal of Ophthalmology 2008; 145(3): 562-9

19. – The Baltimore Pediatric Eye Disease Study, Methods, and Results. Prevalence of Decreased Visual Acuity among Preschool-Aged Children in an American Urban Population. Ophthalmology, 2008; 115: 1786-1795.

20. – Quing Lu et al. A Population-based Study of Visual Impairment Among pre-school Children in Beijing: The Beijing Study of visual impairment in Children. Am J Ophthalmol, 2009; 147: 1075-81.

21.-Friedman et al. Lack of concordance between fixation preference and HOTV Optotype visual acuity in preschool children. The Baltimore Pediatric Eye Disease Study. Ophthalmology.2008; 115: 1796-99.

22.- Holmes JM, Beck RW, et al. s.l The amblyopia treatment study visual acuity testing protocol.. : Arch Ophthalmol. 2001;119: 1345-53.

23.- Estrabismo y Oftalmología Pediátrica. Consejo Argentino de Oftalmología Pediátrica Universidad Católica del Salta, Tratamiento de ambliopía con levodopa. Cap 18. Pg. 335 – 2004

24. Pediatric Eye Disease Investigator Group. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol 2005;123:437-447.

25.Simmonds K. Amblyopia characterization, treatment and prophylaxis. Surv Ophthalmol 2005; 50(2): 123-166.

26.- Epelbaum M, Milleret C, Buisseret P, Dufier JL. The sensitive period for strabismic amblyopia in humans. Ophthalmology 1993; 100: 323-7.

27.- Mohammad A Rashad, Pharmacological enhancement of treatment for amblyopia. Clinical Ophthalmology 2012:6 409–416.

28.- Rahi J, Logan S, Timms C, Russell-Eggitt I, Taylor DSI. Incidence andcauses of new visual loss affecting the non amblyopic eye of individualswith unilateral amblyopia in United Kingdom. Invest Ophthalmol Vis Sci. 2000;41:297.

29.- Grosvenor, Theodore (2007). Primary care Optometry. St. Louis, Missouri: ELSEVIER. pp. 174–175. ISBN 9780750675758.


31.- Bailey IL, Lovie JE. I (1976.) New design principles for visual acuity letter charts. Am J Optom Physiol Opt. Nov;53(11):740-5.

32.- Carlson, Kurts, Nancy, Daniel (2004). Clinical Procedures of Ocular Examination. U.S.A: McGraw HIll. p. 10. ISBN 0-07-137078-1.

33.- Virgili G, Acosta R, Grover LL, Bentley SA, Giacomelli G (2013). «Reading aids for adults with low vision». Cochrane Database Syst Rev 10: CD003303. doi:10.1002/14651858.CD003303.pub3. PMID 24154864.

34.- Mohammad A Rashad Pharmacological enhancement of treatment for amblyopia, Clinical Ophthalmology 2012:6